Advancing Patient Pathways^TM

Elie has 20 years of successful management experience in digital health. Elie has been involved in the creation of two previous digital health start-ups, has directed teams in the public and the private sector, and has been the CEO of Orange Healthcare (a subsidiary of Orange Business Services dedicated to e-health). He is an Engineer from Ecole Centrale Paris (France) and from Cornell University (USA), holds a PhD in Neuroimaging, and has also studied Medicine at Pitie-Salpetriere Hospital in Paris. Elie is the CEO of RDS SAS since its incorporation at the beginning of 2020.

Michel has 30 years of experience as an investor and has as an extensive and successful track record of major investment decisions in the fields of Energy and Health, in Europe and the US. He is the cofounder of Demeter Investment Fund and has been a board member of several risk capital funds including Sofinnova. Michel is a key player in the development of a strong startup ecosystem in the Grand Est region of France. Michel is an Engineer from Toulouse (France), holds a PhD from McGill University (Canada), and has studied management at Harvard Business School (USA).

Sam has 40 years of experience as manager and investor. As a serial entrepreneur, he has been the founder of several major successes such as Applied Biosystems, Lynx Therapeutics, Compass Genetics and Andrew Alliance. He is an Engineer from Grenoble (France), holds a PhD in Biophysics from the University of California in Berkeley (USA), and collaborated for many years with Sidney Brenner who was awarded the Nobel Prize in Physiology and Medicine in 2002.

Jeff has 30 years of experience in medical, biotech, and consumer electronics. Jeff received a BSEE from Cornell University (USA) and an MBA from Stanford’s Graduate School of Business (USA). Out of college, he started with Hewlett Packard as a manufacturing engineer, and then joined Sam Eletr at Applied Biosystems as an electronics design engineer. Jeff later worked at Sony Corporation, working in Tokyo (Japan) in international business development for the first Electronic Book project.

Sophie has an MEng and aPhD in Biotechnology at UTC Compiègne, and also holds a HEC MBA. She is a medtech entrepreneur, and has previously been General Manager of Livanova France & UK, CCO of Mauna Kea technologies and CEO of Cellnovo. She now is a partner at Agile Capital Markets.

Piero has a Master and PhD in Physics from Ferrara University. He started his career as a scientist at CERN, and then became CSO SpinX Technologies, and later CEO of Andrew Alliance until its successful acquisition by Waters in 2020. He authored or contributed to more than 100 publications, and is now involved as a business angel in several startups including RDS.

Christian has a PhD in Biochemistry and is a co-founder of RDS. He worked previously at Sanofi as executive VP for diagnostic, agro-veterinary and capital development, and then at Institut Pasteur as executive VP technology transfer. He was also chairman of Cellectis. He now seats at the boards of several life science companies (including RDS) and charities.